News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,049 Results
Type
Article (14493)
Company Profile (114)
Press Release (351442)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112675)
Career Advice (456)
Deals (18616)
Drug Delivery (29)
Drug Development (31208)
Employer Resources (50)
FDA (8800)
Job Trends (7677)
News (172832)
Policy (12364)
Tag
Academia (1327)
Accelerated approval (3)
Allergies (42)
Alliances (34847)
ALS (28)
Alzheimer's disease (520)
Antibody-drug conjugate (ADC) (78)
Approvals (8834)
Artificial intelligence (254)
Autoimmune disease (5)
Automation (13)
Bankruptcy (131)
Best Places to Work (6524)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1086)
Cardiovascular disease (68)
Career advice (408)
Career pathing (9)
CAR-T (110)
Cell therapy (283)
Cervical cancer (11)
Clinical research (24575)
Collaboration (630)
Compensation (118)
Complete response letters (3)
COVID-19 (1149)
CRISPR (41)
C-suite (153)
Cystic fibrosis (47)
Data (1054)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4930)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38934)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51577)
Executive appointments (422)
FDA (9515)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (497)
Gene editing (94)
Generative AI (24)
Gene therapy (184)
GLP-1 (229)
Government (1235)
Grass and pollen (2)
Guidances (75)
Healthcare (9897)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (32)
Indications (13)
Infectious disease (1227)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8018)
IRA (8)
Job creations (1436)
Job search strategy (362)
Kidney cancer (4)
Labor market (10)
Layoffs (117)
Leadership (3)
Legal (2521)
Liver cancer (36)
Lung cancer (130)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (197)
MASH (16)
Medical device (11508)
Medtech (11513)
Mergers & acquisitions (10966)
Metabolic disorders (226)
Multiple sclerosis (30)
NASH (3)
Neurodegenerative disease (32)
Neuropsychiatric disorders (4)
Neuroscience (725)
NextGen: Class of 2025 (3538)
Non-profit (1522)
Now hiring (9)
Obesity (95)
Opinion (77)
Ovarian cancer (40)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (68)
Partnered (12)
Patents (155)
Patient recruitment (59)
Peanut (26)
People (32830)
Pharmaceutical (16)
Phase I (9064)
Phase II (11087)
Phase III (7191)
Pipeline (639)
Policy (32)
Postmarket research (501)
Preclinical (4109)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (138)
Real estate (3365)
Recruiting (20)
Regulatory (9427)
Reports (18)
Research institute (1272)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (90)
Series B (55)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2509)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (328)
Venture capitalists (19)
Weight loss (35)
Women's health (17)
Worklife (2)
Date
Today (106)
Last 7 days (449)
Last 30 days (1567)
Last 365 days (17059)
2025 (6008)
2024 (18721)
2023 (22108)
2022 (30831)
2021 (32523)
2020 (30558)
2019 (25803)
2018 (19464)
2017 (18877)
2016 (17764)
2015 (20569)
2014 (15190)
2013 (12747)
2012 (13787)
2011 (14068)
2010 (12831)
Location
Africa (318)
Alabama (41)
Alaska (6)
Arizona (126)
Arkansas (10)
Asia (24123)
Australia (4194)
California (3087)
Canada (1077)
China (253)
Colorado (174)
Connecticut (132)
Delaware (49)
Europe (49313)
Florida (506)
Georgia (141)
Idaho (33)
Illinois (295)
India (13)
Indiana (169)
Iowa (5)
Japan (125)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (477)
Massachusetts (2139)
Michigan (189)
Minnesota (260)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (25)
New Hampshire (67)
New Jersey (957)
New Mexico (16)
New York (900)
North Carolina (550)
North Dakota (8)
Northern California (1171)
Ohio (106)
Oklahoma (11)
Oregon (20)
Pennsylvania (626)
Puerto Rico (11)
Rhode Island (25)
South America (507)
South Carolina (23)
South Dakota (1)
Southern California (1266)
Tennessee (64)
Texas (499)
United States (12162)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (41)
366,049 Results for "biologica technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Biologica Technologies® signs agreements with Premier Inc. and Academy Medical
Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced two significant, separate agreements signed with Premier Inc. and Academy Medical.
April 4, 2023
·
2 min read
Deals
Advanced Biologics Elevates Biologic Innovations Through Merger with Isto Biologics.
Advanced Biologics (known commercially as Biologica Technologies), a California-based company known for their innovative biologic solutions, announced today their successful merger with Isto Biologics, a global leader in regenerative and autologous therapies.
October 18, 2023
·
3 min read
Biotech Beach
Biologica Technologies® announces the presentation of ProteiOS® clinical data at the North American Spine Society 36th Annual Meeting in Boston
Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced today the podium presentation, ‘Retrospective assessment of radiographic outcomes after implantation of a novel allograft growth factor combined with scaffold in patients undergoing XLIF, LLIF, and TLIF procedures’
September 30, 2021
·
2 min read
Biotech Beach
Biologica Technologies® showcases latest clinical data of ProteiOS® at the Annual Scientific Conference of the American College of Foot and Ankle Surgeons (ACFAS)
Biologica Technologies, developers and marketers of ProteiOS ® growth factor and OsseoGEN ® cellular bone matrix, announced today the early topline results from a retrospective, multicenter study evaluating the safety and effectiveness of ProteiOS in foot and ankle arthrodesis (fusion) procedures.
May 18, 2021
·
2 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
MicroSurgical Technology (MST) Advances Leadership in Vitrectomy Technology with Presentations at ASCRS 2025 Annual Meeting
April 22, 2025
·
3 min read
Biotech Beach
Biologica Technologies Named to MedTech Outlook’s Top 10 MedTech Startups of 2019
Biologica Technologies, developers and marketers of ProteiOS®, announced today that they have been recognized as one of the Top 10 MedTech Startups in 2019 by MedTech Outlook Magazine.
October 14, 2019
·
1 min read
Business
Biologica Technologies announces expansion and relocation of head office
Biologica Technologies, LLC is excited to announce the relocation and expansion of its head office to a larger facility within the same city of Carlsbad, CA.
May 14, 2019
·
1 min read
Press Releases
Palatin Technologies Announces Closing of Reduced Public Offering
May 9, 2025
·
5 min read
Press Releases
Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray
April 16, 2025
·
4 min read
1 of 36,605
Next
